The new Network is a collaboration of technology vendors, contract research organizations and service providers that support the life sciences value chain. It is designed to help streamline and accelerate life-cycle processes through an integrated information platform that manages and analyzes data from multiple diverse systems.
The Life Sciences Network also plans to offer technology including electronic data capture (EDC), electronic patient diaries (EPDs), interactive voice response (IVR) systems, central labs, safety and medical coding, electronic submissions and post-approval studies and registries.
At the core of the Network is SAS’ Drug Development tool, which the company said will serve as the hub for streamlining and accelerating the process of managing pharmaceutical, biotechnology and medical device data.
SAS hopes the product will help users to secure regulatory approval for products more quickly and keep them on the market.
The Life Sciences Network enables life sciences firms to drastically reduce the risk, time and expense in adopting new technologies for the variety of processes they use on their data, said Kecia Serwin, general manager of SAS Health and Life Sciences. With the Life Sciences Network, firms can use the premier software and services on the market today to create a cost-effective, integrated system with a single hub for delivering top-of-the-line capabilities.
